Please provide your email address to receive an email when new articles are posted on . The photopneumatic device improved acne in 66.7% of patients in this 7-week trial. Improvements were seen across ...
Please provide your email address to receive an email when new articles are posted on . After 12 weeks, researchers observed a 23.4% improvement in overall photodamage in Fitzpatrick skin types I to ...
(RTTNews) - Arcutis Biotherapeutics Inc.'s (ARQT) ZORYVE cream 0.15% provided consistent and meaningful improvements in signs and symptoms of atopic dermatitis in individuals regardless of race, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results